Fighting the COVID-19 Globally: Ovation Science (CSE:OVAT) DermSafe® Hand Sanitizer

Ovation Science Interview
Published on: March 30, 2020
Author: Editor

With a worldwide pandemic due the coronavirus COVID-19, Ovation Science Inc. (CSE: OVAT) is focused on providing DermSafe® hand sanitizer globally.The public needs to take a PREVENTATIVE approach to their health and safety and DermSafe® does exactly that. Last Tuesday, Gilbert Chan, the president of NAI500, sat down with Terry Howlett, the President and Chief Executive Officer of Ovation, to talk about Ovation’s DermSafe® and its market potential.

Coronavirus declared a pandemic as Ovation receives interest for DermSafe® from more countries with the coronavirus (COVID-19). DermSafe® is a non-alcohol hand sanitizer made with chlorhexidine gluconate; kills germs for up to four hours. Learn more at https://ovationscience.com/products/

Ovation Science Inc. is a research and development company that develops topical and transdermal cannabis and hemp formulations as well as other consumer goods made with patented Invisicare® skin delivery technology. The technology enhances the delivery of cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) to and through the skin and is protected by patents in eleven countries. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation’s management and science team have created a unique pipeline of over twenty-five patent-protected medical / wellness topical and transdermal cannabis products incorporating CBD, THC and combination products along with a line of anti-aging / beauty products made with CBD. Ovation’s business model is to develop and market its two product lines ARLO CBD Beauty and Invibe MD, our health and wellness line, as well as continuing to out-license its topical and transdermal formulations to cannabis companies globally. Ovation formulated CBD and THC products are marketed in Nevada in state-approved dispensaries by its US licensee with additional states being added. Ovation earns revenues from licensing and development fees, royalties, the sale of Invisicare to its licensees and now revenue from its own product sales.  Ovation has offices in Vancouver, BC Canada and Las Vegas, Nevada, USA. Ovation trades on the CSE under the symbol OVAT. Visit Ovation Science website www.ovationscience.com

Disclaimer: NAI is being compensated for this content. Materials contained in this content are for information purposes only and is not intended to constitute an offering of securities in any jurisdiction. Nothing on this content should be construed as an offer, solicitation or recommendation to buy or sell products or securities. 

Coronavirus COVID-19 Novel Coronavirus Pneumonia